PSI Advisors LLC grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 68.3% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 557 shares of the healthcare conglomerate’s stock after buying an additional 226 shares during the period. PSI Advisors LLC’s holdings in UnitedHealth Group were worth $282,000 as of its most recent filing with the SEC.
A number of other institutional investors and hedge funds have also modified their holdings of UNH. Hanson & Doremus Investment Management increased its stake in UnitedHealth Group by 10.9% in the second quarter. Hanson & Doremus Investment Management now owns 459 shares of the healthcare conglomerate’s stock valued at $234,000 after acquiring an additional 45 shares during the period. Retirement Planning Co of New England Inc. raised its holdings in shares of UnitedHealth Group by 5.4% in the 2nd quarter. Retirement Planning Co of New England Inc. now owns 448 shares of the healthcare conglomerate’s stock worth $228,000 after buying an additional 23 shares in the last quarter. WINTON GROUP Ltd acquired a new stake in UnitedHealth Group in the 2nd quarter valued at $228,000. Fairfield Financial Advisors LTD bought a new position in shares of UnitedHealth Group during the second quarter valued at $2,194,000. Finally, Capital Wealth Planning LLC grew its holdings in shares of UnitedHealth Group by 4.1% in the 2nd quarter. Capital Wealth Planning LLC now owns 1,016,952 shares of the healthcare conglomerate’s stock worth $517,893,000 after purchasing an additional 39,713 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research firms have commented on UNH. Morgan Stanley reduced their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. TD Cowen increased their price objective on shares of UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Royal Bank of Canada cut their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Barclays increased their price target on shares of UnitedHealth Group from $603.00 to $655.00 and gave the company an “overweight” rating in a research report on Wednesday, November 27th. Finally, Bank of America dropped their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, UnitedHealth Group has an average rating of “Buy” and an average target price of $626.79.
UnitedHealth Group Stock Up 4.0 %
NYSE UNH opened at $541.28 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a market capitalization of $498.13 billion, a PE ratio of 35.26, a PEG ratio of 1.53 and a beta of 0.62. The business has a fifty day moving average price of $554.92 and a two-hundred day moving average price of $562.88.
UnitedHealth Group (NYSE:UNH – Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company’s revenue was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $6.56 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th were given a $2.10 dividend. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- What Are the FAANG Stocks and Are They Good Investments?
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- How to trade using analyst ratings
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Using the MarketBeat Dividend Yield Calculator
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.